Cypherpunk Technologies (CYPH) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
15 Dec, 2025Opening remarks and agenda
The meeting was called to order at 11:00 A.M. on December 15, 2025, as a virtual special meeting with an agenda and rules of conduct accessible to all stockholders.
The Chair introduced the Inspector of Elections and outside counsel, and confirmed the meeting would follow the published agenda.
Shareholder proposals
Proposals included increasing authorized shares to 500 million, a reverse stock split (1:5 to 1:20), adoption of a 2025 Equity Incentive Plan, approval for a private placement issuance exceeding 19.99% of outstanding shares, and the ability to adjourn if needed for more proxies.
Overview of voting outcomes
29,990,907 shares voted for the authorized share increase.
36,314,864 shares voted for the reverse split proposal.
28,765,316 shares voted for the 2025 equity incentive plan.
403,379 shares voted for the private placement issuance.
35,080,571 shares voted for the adjournment proposal.
Latest events from Cypherpunk Technologies
- Returned to profitability in 2025 with strong ZEC gains, new capital, and clinical progress.CYPH
Q4 202516 Mar 2026 - Phase 2 trials for DKN-01 in gastric and colorectal cancer near key data readouts and expansion.CYPH
Piper Sandler 36th Annual Healthcare Conference11 Jan 2026 - Sirexatamab shows strong efficacy in GI cancer trials; FL-501 advances toward clinical studies.CYPH
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Sirexatamab improved response rates in CRC, especially in DKK1-high and VEGF-naive patients.CYPH
Study Result9 Jan 2026 - Virtual meeting to elect directors, approve pay, and ratify auditor, with strong governance.CYPH
Proxy Filing2 Dec 2025 - Stockholders to vote on key capital, governance, and compensation proposals; Board urges approval.CYPH
Proxy Filing2 Dec 2025 - Stockholders will vote on key capital structure changes and equity plans at a virtual meeting.CYPH
Proxy Filing2 Dec 2025 - Virtual annual meeting on June 18, 2025, with key votes on directors, pay, and auditor.CYPH
Proxy Filing2 Dec 2025 - Sirexatamab delivers higher response rates and PFS in key colorectal cancer subgroups.CYPH
Status Update24 Nov 2025